Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07353892 · ClinicalTrials.gov registry record · NA
Robotic Exoskeletons in Acute Care Therapy
A NA study of Patients Post-cardiothoracic Surgery, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07353892: Recruiting NA study of Patients Post-cardiothoracic Surgery, sponsored by Baylor Research Institute.
NCT07353892 is a NA study of Patients Post-cardiothoracic Surgery that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07353892, a NA study of Patients Post-cardiothoracic Surgery, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to establish the safety, feasibility, and preliminary findings of overground robotic exoskeleton early ambulation (ORE-EA) compared to usual care early ambulation (UC-EA) in the rehabilitation of patients who have had cardiovascular or thoracic surgery. The main questions it aims to answer are: * Is there a difference between groups in time between surgery and ambulation? * Are there differences in safety and feasibility?
Primary Outcome
Time from admission in the ICU to the first upright ambulation session (in hours), assessed up to 12 months from admission.
Conditions Studied
Interventions
- DEVICE Overground robotic exoskeleton early ambulation (ORE-EA)
- OTHER Usual care early ambulation (UC-EA)
Study Locations (1)
Texas
- Baylor Institute for Rehabilitation - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-12-02 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
What NCT07353892 shows while recruiting
NCT07353892 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Patients Post-cardiothoracic Surgery appearing as the primary indexed condition, and to 2 interventions - of which Overground robotic exoskeleton early ambulation (ORE-EA) is the first listed.
NCT07353892 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07353892 about?
NCT07353892 is a clinical study titled "Robotic Exoskeletons in Acute Care Therapy". The goal of this clinical trial is to establish the safety, feasibility, and preliminary findings of overground robotic exoskeleton early ambulation (ORE-EA) compared to usual care early ambulation (UC-EA) in the rehabilitation of patients who have had cardiovascular or thoracic surgery. The main qu...
What is the current status of trial NCT07353892?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-12-02. Estimated completion is 2027-07-01.
What conditions does trial NCT07353892 study?
This clinical trial studies the following conditions: Patients Post-cardiothoracic Surgery.
What interventions are being tested in trial NCT07353892?
The interventions under investigation include: Overground robotic exoskeleton early ambulation (ORE-EA) (DEVICE), Usual care early ambulation (UC-EA) (OTHER).
Who is sponsoring clinical trial NCT07353892?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07353892 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07353892's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI